Table 4. Average percent change of mRNAs at end treatment relative to pre-treatment.
mRNA | BSH Dose | ||
---|---|---|---|
50g | 100g | 150g | |
hmox1 | +65.5% | +41.8% | +53.5%* |
nqo1 | +44.2% | +14.4% | -0.7% |
hbg1 | +65.2% | +130.8%* | +21.6% |
hbg1/(hbb+hbg1) | -1.4% | +2.6% | +10.7% |
*significant difference between pre-treatment and end treatment (p <0.05)